Evidence map›Paper›PMID 39305038›Full record

ArticleArchiv der Pharmazie2024

iNOS/PGE

Ayca Erdogan, Yagmur Ozhan, Hande Sipahi, Enise Ece Gurdal, Wolfgang Sippl, Meric Koksal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archiv der Pharmazie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. iNOS/PGEArchiv der Pharmazie · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ayca ErdoganDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Yeditepe University, Istanbul, Turkey.
Yagmur OzhanDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Yeditepe University, Istanbul, Turkey.
Hande SipahiDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Yeditepe University, Istanbul, Turkey.
Enise Ece GurdalDepartment of Organic Chemistry, Faculty of Chemistry, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Wolfgang SipplDepartment of Medicinal Chemistry, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.ORCID http://orcid.org/0000-0002-5985-9261
Meric KoksalDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Yeditepe University, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-7662-9364

Funding

Yeditepe University YAP-AP-SAB-22025
6 · The paper itself

Abstract

Due to the serious gastrointestinal side effects associated with prolonged use of current anti-inflammatory therapies, various strategies such as the regulation of nitric oxide (NO) and prostaglandin E

Indexed as

DinoprostoneDrug DesignMolecular Docking SimulationNitric Oxide Synthase Type IIAnalgesicsAnimalsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalDose-Response Relationship, DrugInterleukin-6Interleukin-6 InhibitorsLipopolysaccharidesMiceMolecular StructureNitric OxideOxadiazoles1,2,4-triazole1,3,4-oxadiazoleAnalgesicsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalDinoprostoneInterleukin-6Interleukin-6 InhibitorsLipopolysaccharidesNitric OxideNitric Oxide Synthase Type IIOxadiazolesTriazoles1,2,4‐triazolo[3,4‐b][1,3,4]thiadiazines1,3,4‐oxadiazolesanti‐inflammatory activityiNOS/PGE2 inhibitorsmolecular docking

Identifiers

PMID39305038
PMCPMC11609903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.